Relationship between adjunctive medications for anxiety and time spent ill in patients with bipolar disorder

References

• Bauer MS, Whybrow PC, Gyulai L, Gonnel J, Yeh HS. Testing definitions of dysphoric mania and hypomania: prevalence, clinical characteristics and inter-episode stability. J Affect Disord 1994; 32: 201–11
   PubMed Web of Science ®Google Scholar
• Cassidy F, Murry E, Forest K, Carroll BJ. Signs and symptoms of mania in pure and mixed episodes. J Affect Disord 1998; 50: 187–201
   PubMed Web of Science ®Google Scholar
• Maj M, Pirozzi R, Magliano L, Bartoli L. Agitated depression in bipolar I disorder: prevalence, phenomenology, and outcome. Am J Psychiatry 2003; 160: 2134–40
   PubMed Web of Science ®Google Scholar
• Benazzi F, Koukopoulos A, Akiskal HS. Toward a validation of a new definition of agitated depression as a bipolar mixed state (mixed depression). Eur Psychiatry 2004; 19: 85–90
   PubMed Web of Science ®Google Scholar
• Akiskal HS, Benazzi F, Perugi G, Rihmer Z. Agitated “unipolar” depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy. J Affect Disord 2005; 85: 245–58
   PubMed Web of Science ®Google Scholar
• Henry C, M'Baïlara K, Poinsot R, Casteret AA, Sorbara F, Leboyer M, et al. Evidence for two types of bipolar depression using a dimensional approach. Psychother Psychosom 2007; 76: 325–31
   PubMed Web of Science ®Google Scholar
• Pini S, Cassano GB, Simonini E, Savino M, Russo A, Montgomery SA. Prevalence of anxiety disorders comorbidity in bipolar depression, unipolar depression and dysthymia. J Affect Disord 1997; 42: 145–53
   PubMed Web of Science ®Google Scholar
• Angst J. The emerging epidemiology of hypomania and bipolar II disorder. J Affect Disord 1998; 50: 143–51
   PubMed Web of Science ®Google Scholar
• Freeman MP, Freeman SA, McElroy SL. The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology, and treatment issues. J Affect Disord 2002; 68: 1–23
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Soczynska JK, Bottas A, Bordbar K, Konarski JZ, Kennedy SH. Anxiety disorders and bipolar disorder: a review. Bipolar Disord 2006; 8: 665–76
   PubMed Web of Science ®Google Scholar
• Frank E, Cyranowski JM, Rucci P, Shear MK, Fagiolini A, Thase ME, et al. Clinical significance of lifetime panic spectrum symptoms in the treatment of patients with bipolar I disorder. Arch Gen Psychiatry 2002; 59: 905–11
   PubMed Web of Science ®Google Scholar
• Simon NM, Zalta AK, Otto MW, Ostacher MJ, Fischmann D, Chow CW, et al. The association of comorbid anxiety disorders with suicide attempts and suicidal ideation in outpatients with bipolar disorder. J Psychiatr Res 2007; 41: 255–64
   PubMed Web of Science ®Google Scholar
• MacQueen GM, Marriott M, Begin H, Robb J, Joffe RT, Young LT. Subsyndromal symptoms assessed in longitudinal, prospective follow-up of a cohort of patients with bipolar disorder. Bipolar Disord 2003; 5: 349–55
   PubMed Web of Science ®Google Scholar
• Boylan KR, Bieling PJ, Marriott M, Begin H, Young LT, MacQueen GM. Impact of comorbid anxiety disorders on outcome in a cohort of patients with bipolar disorder. J Clin Psychiatry 2004; 65: 1106–13
   PubMed Web of Science ®Google Scholar
• Otto MW, Simon NM, Wisniewski SR, Miklowitz DJ, Kogan JN, Reilly-Harrington NA, et al. Prospective 12-month course of bipolar disorder in out-patients with and without comorbid anxiety disorders. Br J Psychiatry 2006; 189: 20–5
   PubMed Web of Science ®Google Scholar
• Feske U, Frank E, Mallinger AG, Houck PR, Fagiolini A, Shear MK, et al. Anxiety as a correlate of response to the acute treatment of bipolar I disorder. Am J Psychiatry 2000; 157: 956–62
   PubMed Web of Science ®Google Scholar
• Henry C, Van den Bulke D, Bellivier F, Etain B, Rouillon F, Leboyer M. Anxiety disorders in 318 bipolar patients: prevalence and impact on illness severity and response to mood stabilizer. J Clin Psychiatry 2003; 64: 331–5
   PubMed Web of Science ®Google Scholar
• Tohen M, Calabrese J, Vieta E, Bowden C, Gonzalez-Pinto A, Lin D, et al. Effect of comorbid anxiety on treatment response in bipolar depression. J Affect Disord 2007; 104: 137–46
   PubMed Web of Science ®Google Scholar
• McElroy SL, Altshuler LL, Suppes T, Keck PE, Jr, Frye MA, Denicoff KD, et al. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry 2001; 158: 420–6
   PubMed Web of Science ®Google Scholar
• Simon NM, Otto MW, Wisniewski SR, Fossey M, Sagduyu K, Frank E, et al. Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry 2004; 161: 2222–29
   PubMed Web of Science ®Google Scholar
• Young LT, Cooke RG, Robb JC, Levitt AJ, Joffe RT Anxious and non-anxious bipolar disorder. J Affect Disord 1993;29:49–52.
   PubMed Web of Science ®Google Scholar
• Kauer-Sant'Anna M, Frey BN, Andreazza AC, Ceresér KM, Gazalle FK, Tramontina J, et al. Anxiety comorbidity and quality of life in bipolar disorder patients. Can J Psychiatry 2007; 52: 175–81
   PubMed Web of Science ®Google Scholar
• Simon NM, Otto MW, Weiss RD, Bauer MS, Miyahara S, Wisniewski SR, et al. Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD. J Clin Psychopharmacol 2004; 24: 512–20
   PubMed Web of Science ®Google Scholar
• Bauer M, Glenn T, Grof P, Rasgon NL, Marsh W, Sagduyu K, , et al Relationship between subsyndromal symptoms and employment status in patients with bipolar disorder. Submitted manuscript.
   Google Scholar
• Bauer MS, Crits-Christoph P, Ball WA, Dewees E, McAllister T, Alahi P, et al. Independent assessment of manic and depressive symptoms by self-rating. Scale characteristics and implications for the study of mania. Arch Gen Psychiatry 1991; 48: 807–12
   PubMed Web of Science ®Google Scholar
• Whybrow PC, Grof P, Gyulai L, Rasgon N, Glenn T, Bauer M. The electronic assessment of the longitudinal course of bipolar disorder: The ChronoRecord software. Pharmacopsychiatry 2003; 36(Suppl 3)S244–9
   PubMedGoogle Scholar
• Bauer M, Grof P, Gyulai L, Rasgon N, Glenn T, Whybrow PC. Using Technology to Improve Longitudinal Studies: Self-Reporting in Bipolar Disorder. Bipolar Disord 2004; 6: 67–74
   PubMed Web of Science ®Google Scholar
• Bauer M, Wilson T, Neuhaus K, Sasse J, Pfennig A, Lewitzka U, et al. Self-reporting software for bipolar disorder: validation of ChronoRecord by patients with mania. Psychiatry Res 2008; 159: 359–66
   PubMed Web of Science ®Google Scholar
• Bauer M, Glenn T, Grof P, Pfennig A, Rasgon NL, Marsh W, et al. Self-reported data from patients with bipolar disorder: frequency of brief depression. J Affect Disord 2007; 101: 227–33
   PubMed Web of Science ®Google Scholar
• Perugi G, Toni C, Frare F, Ruffolo G, Moretti L, Torti C, et al. Effectiveness of adjunctive gabapentin in resistant bipolar disorder: is it due to anxious-alcohol abuse comorbidity?. J Clin Psychopharmacol 2002; 22: 584–91
   PubMed Web of Science ®Google Scholar
• Carta MG, Hardoy MC, Hardoy MJ, Grunze H, Carpiniello B. The clinical use of gabapentin in bipolar spectrum disorders. J Affect Disord 2003; 75: 83–91
   PubMed Web of Science ®Google Scholar
• Pollack MH, Matthews J, Scott EL. Gabapentin as a potential treatment for anxiety disorders. Am J Psychiatry 1998; 155: 992–3
   PubMed Web of Science ®Google Scholar
• Pande AC, Davidson JR, Jefferson JW, Janney CA, Katzelnick DJ, Weisler RH, et al. Treatment of social phobia with gabapentin: a placebo-controlled study. J Clin Psychopharmacol 1999; 19: 341–8
   PubMed Web of Science ®Google Scholar
• Pande AC, Pollack MH, Crockatt J, Greiner M, Chouinard G, Lydiard RB, et al. Placebo-controlled study of gabapentin treatment of panic disorder. J Clin Psychopharmacol 2000; 20: 467–71
   PubMed Web of Science ®Google Scholar
• Pande AC, Crockatt JG, Feltner DE, Janney CA, Smith WT, Weisler R, et al. Pregabalin in generalized anxiety disorder: a placebo-controlled trial. Am J Psychiatry 2003; 160: 533–40
   PubMed Web of Science ®Google Scholar
• Rickels K, Pollack MH, Feltner DE, Lydiard RB, Zimbroff DL, Bielski RJ, et al. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam. Arch Gen Psychiatry 2005; 62: 1022–30
   PubMed Web of Science ®Google Scholar
• Denicoff KD, Smith-Jackson EE, Disney ER, Suddath RL, Leverich GS, Post RM. Preliminary evidence of the reliability and validity of the prospective life-chart methodology (LCM-p). J Psychiatr Res 1997; 31: 593–603
   PubMed Web of Science ®Google Scholar
• Lish JD, Dime-Meenan S, Whybrow PC, Price RA, Hirschfeld RM. The National Depressive and Manic-Depressive Association (DMDA) survey of bipolar members. J Affect Disord 1994; 31: 281–94
   PubMed Web of Science ®Google Scholar
• Ghaemi SN: Anxiety and bipolar disorder. Medscape Family Medicine/Primary Care 2004;6.
   Google Scholar
• Singh JB, Zarate CA, Jr. Pharmacological treatment of psychiatric comorbidity in bipolar disorder: a review of controlled trials. Bipolar Disord 2006; 8: 696–709
   PubMed Web of Science ®Google Scholar
• Pillay SS. Polypharmacy of anxiety disorders. Polypharmacy in psychiatry, SN Ghaemi. Informa Healthcare, New York 2002; 134–5
   Google Scholar
• Ghaemi SN, Hsu DJ, Soldani F, Goodwin FK. Antidepressants in bipolar disorder: the case for caution. Bipolar Disord 2003; 5: 421–33
   PubMed Web of Science ®Google Scholar
• Young LT, Joffe RT, Robb JC, MacQueen GM, Marriott M, Patelis-Siotis I. Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression. Am J Psychiatry 2000; 157: 124–6
   PubMed Web of Science ®Google Scholar
• Gijsman HJ, Geddes JR, Rendell JM, Nolen WA, Goodwin GM. Antidepressants for bipolar depression: a systematic review of randomized, controlled trials. Am J Psychiatry 2004; 161: 1537–47
   PubMed Web of Science ®Google Scholar
• Bauer M, Rasgon N, Grof P, Glenn T, Lapp M, Marsh W, et al. Do antidepressants influence mood patterns? A naturalistic study in bipolar disorder. Eur Psychiatry 2006; 21: 262–9
   PubMed Web of Science ®Google Scholar
• Vieta E. Case for caution, case for action. Bipolar Disord 2003; 5: 434–5
   PubMed Web of Science ®Google Scholar
• Benazzi F. Suicidal ideation and depressive mixed states. Psychother Psychosom 2005; 74: 61–2
   PubMed Web of Science ®Google Scholar
• Benazzi F. Reviewing the diagnostic validity and utility of mixed depression (depressive mixed states). Eur Psychiatry 2008; 23: 40–8
   PubMed Web of Science ®Google Scholar
• Bowen RC, D'Arcy C. Response of patients with panic disorder and symptoms of hypomania to cognitive behavior therapy for panic. Bipolar Disord 2003; 5: 144–9
   PubMed Web of Science ®Google Scholar
• Chouinard G, Young SN, Annable L. Antimanic effect of clonazepam. Biol Psychiatry 1983; 18: 451–66
   PubMed Web of Science ®Google Scholar
• Sachs GS. Use of clonazepam for bipolar affective disorder. J Clin Psychiatry 1990; 51(Suppl 3)1–4
   Google Scholar
• Lenox RH, Newhouse PA, Creelman WL, Whitaker TM. Adjunctive treatment of manic agitation with lorazepam versus haloperidol: a double-blind study. J Clin Psychiatry 1992; 53: 47–52
   PubMed Web of Science ®Google Scholar
• Schatzberg AF, Cole J, Debattista C. Manual of clinical psychopharmacology4th ed. American Psychiatric Association, Washington, DC 2002; 305–7
   Google Scholar
• Goodwin FK, Jamison KR: Manic-depressive illness. New York: Oxford University Press; 1990. p 665–724.
   Google Scholar
• Winkler D, Willeit M, Wolf R, Stamenkovic M, Tauscher J, Pjrek E, et al. Clonazepam in the long-term treatment of patients with unipolar depression, bipolar and schizoaffective disorder. Eur Neuropsychopharmacol 2003; 13: 129–34
   PubMed Web of Science ®Google Scholar
• Brunette MF, Noordsy DL, Xie H, Drake RE. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders. Psychiatr Serv 2003; 54: 1395–401
   PubMed Web of Science ®Google Scholar
• Salzman C. Benzodiazepine dependence, toxicity and abuse: A Task Force of the American Psychiatric Association. American Psychiatric Association, Washington, DC 1990
   Google Scholar
• Hwang G, Kim HR, Park SH, Kim SH, Park SR, Kim GH. Do benzodiazepines extend the duration of follow-up treatment in patients with bipolar disorder?. Hum Psychopharmacol 2006; 21: 319–25
   PubMed Web of Science ®Google Scholar
• Maina G, Albert U, Rosso G, Bogetto F. Olanzapine or lamotrigine addition to lithium in remitted bipolar disorder patients with anxiety disorder comorbidity: a randomized, single-blind, pilot study. J Clin Psychiatry 2008; 69: 609–16
   PubMed Web of Science ®Google Scholar
• Hirschfeld RM, Weisler RH, Raines SR, Macfadden W; for the BOLDER Study Group. Quetiapine in the treatment of anxiety in patients with bipolar I or II depression: a secondary analysis from a randomized, double-blind, placebo-controlled study. J Clin Psychiatry 2006;67:355–62.
   PubMed Web of Science ®Google Scholar
• Zimmerman M, Posternak M, Friedman M, Attiullah N, Baymiller S, Boland R, et al. Which factors influence psychiatrists’ selection of antidepressants?. Am J Psychiatry 2004; 161: 1285–9
   PubMed Web of Science ®Google Scholar
• Zutshi A, Reddy YC, Thennarasu K, Chandrashekhar CR. Comorbidity of anxiety disorders in patients with remitted bipolar disorder. Eur Arch Psychiatry Clin Neurosci 2006; 256: 428–36
   PubMed Web of Science ®Google Scholar
• MacKinnon DF, Zandi PP, Cooper J, Potash JB, Simpson SG, Gershon E, et al. Comorbid bipolar disorder and panic disorder in families with a high prevalence of bipolar disorder. Am J Psychiatry 2002; 159: 30–5
   PubMed Web of Science ®Google Scholar
• Rotondo A, Mazzanti C, Dell'Osso L, Rucci P, Sullivan P, Bouanani S, et al. Catechol o-methyltransferase, serotonin transporter, and tryptophan hydroxylase gene polymorphisms in bipolar disorder patients with and without comorbid panic disorder. Am J Psychiatry 2002; 159: 23–9
   PubMed Web of Science ®Google Scholar
• Tohen M, Bowden CL, Calabrese JR, Lin D, Forrester TD, Sachs GS, et al. Influence of sub-syndromal symptoms after remission from manic or mixed episodes. Br J Psychiatry 2006; 189: 515–19
   PubMed Web of Science ®Google Scholar
• Judd LL, Schettler PJ, Akiskal HS, Coryell W, Leon AC, Maser JD, et al. Residual symptom recovery from major affective episodes in bipolar disorders and rapid episode relapse/recurrence. Arch Gen Psychiatry 2008; 65: 386–94
   PubMed Web of Science ®Google Scholar
• Altshuler LL, Post RM, Black DO, Keck PE, Jr, Nolen WA, Frye MA, et al. Subsyndromal depressive symptoms are associated with functional impairment in patients with bipolar disorder: results of a large, multisite study. J Clin Psychiatry 2006; 67: 1551–60
   PubMed Web of Science ®Google Scholar
• Huxley N, Baldessarini RJ. Disability and its treatment in bipolar disorder patients. Bipolar Disord 2007; 9: 183–96
   PubMed Web of Science ®Google Scholar